Two distinct NF[kappa]B signaling pathways have been described; the canonical pathway that mediates inflammatory responses, and the non-canonical pathway that is involved in immune system development. The former is dependent on the I[kappa]B kinase adaptor molecule NEMO, and the latter is independent of it. My dissertation encompasses approaches including biochemistry, molecular biology, mouse genetics and computational simulations to investigate potential crosstalk mechanisms between these two pathways. Specifically, I describe evidence for two distinct mechanisms by which the non-canonical NF[kappa]B pathway determines the responsiveness of canonical pathway to inflammatory signals. In the first mechanism, low homeostatic non-canonical signaling in tissue fibroblasts allows for accumulation of the non-canonical I[kappa]B, I[kappa]B[delta], during pathogen inflammatory exposure. Accumulation of I[kappa]B[delta] thereby 242}0reduces RelA:p50 activity at late time points. In the second mechanism, elevated homeostatic non-canonical signaling in inflammatory dendritic cells results in the formation of a previously overlooked dimer, RelB:p50. RelB:p50 forms a complex with canonical I[kappa]B's and contributes to canonical signaling when cells are exposed to inflammatory stimuli. These observations suggest that NEMO-dependent and independent signaling should be viewed within the context of a single NF[kappa]B signaling system, which mediates signaling from both inflammatory and organogenic stimuli in an integrated manner. Further, homeostatic regulation determines the responsiveness of the signaling system and perturbed homeostatic control renders pathological outcomes. As in other regulatory biological systems, a systems approach, including mathematical models that include quantitative and kinetic information, is useful to characterize the network properties that mediate physiological function, and that may break down to cause or contribute to pathology